Palivizumab

Type: Product
Name: Palivizumab
First reported Jul 28 2014 - Updated 14 hours ago - 2 reports

AAP updates guidance on palivizumab prophylaxis for RSV

The AAP’s Red Book Committee updated guidance for use of palivizumab prophylaxis among infants and young children with increased risk for hospitalization for respiratory syncytial virus infection.The updated recommendations reflect new information regarding ... [Published Orthopedics Today - 14 hours ago]
First reported 18 hours ago - Updated 18 hours ago - 1 reports

Premature Babies Drug in Middle of Clash Between Creator and Pediatrican Group

An expensive drug that is given mainly to premature babies is at the middle of a clash between the creator and the nation’s top pediatrician group, which has recommended cutting back on use of the medication. The clash involves new procedures that have ... [Published The Guardian Express - 18 hours ago]
First reported Jul 28 2014 - Updated 19 hours ago - 4 reports

Pediatricians clash with maker of drug for babies

Leading pediatrician's group says prescription Synagis should not be given to so many kids; drugmaker fires back ... [Published Latest Econwatch Headlines - CBS News - 19 hours ago]
Entities: Drugs, Palivizumab
First reported Jul 25 2014 - Updated Jul 26 2014 - 1 reports

AbbVie's (ABBV) CEO Richard Gonzalez on Q2 2014 Results - Earnings Call Transcript

OperatorGood morning and thank you for standing by. Welcome to the AbbVie Second 2014 Earnings Conference Call. All participants will be able to listen-only. This conference is being recorded by AbbVie.I would now like to introduce Mr. Larry Peepo, Vice ... [Published Seeking Alpha - Jul 25 2014]
First reported Jul 25 2014 - Updated Jul 25 2014 - 1 reports

AbbVie Q2 Profit Rises, Results Beat View; Affirms 2014 Outlook

Research-based biopharmaceutical company AbbVie Inc. (ABBV: Quote) on Friday reported a 3 percent increase in profit for the second quarter from last year on higher revenues, reflecting strong sales of the company's blockbuster rheumatoid arthritis drug ... [Published RTTNews.com - Jul 25 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Market Update (NYSE:ABBV): AbbVie to Host Second-Quarter Earnings Conference Call

[PR Newswire] – AbbVie (ABBV) will announce its second-quarter 2014 financial results on Friday, July 25, 2014, before the market opens. It will be accessible through AbbVie’s Investor Relations website at www.abbvieinvestor.com. In accordance with Rule ... [Published Jutia Group - Jul 23 2014]
First reported Jul 17 2014 - Updated Jul 17 2014 - 1 reports

Prevention and Management of Respiratory Viruses

US Pharm . 2014;39(7):HS2-HS6.ABSTRACT: Respiratory viruses are increasingly recognized as a cause of community-acquired pneumonia in both children and adults. Oseltamivir is recommended for the treatment of influenza virus in the inpatient setting, ... [Published U.S.Pharmacist - Jul 17 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 2 reports

Mikulski tours MedImmune labs, meets with employees

Sen. Barbara Mikulski toured the MedImmune laboratories in Frederick on Monday morning and talked with employees.Mikulski told the workers she was proud of what they are doing, creating medical solutions to health problems. She also talked with company ... [Published Frederick News-Post - Jul 15 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Biosimilars and Biosuperiors Therapeutics Antibodies Market - Global Industry Analysis and Forecast, 2013 – 2019

A biosimilar medicine possesses the similar pharmacokinetic and mode of action as an original biological medicine that has already been approved for therapeutic use. Biosimilars are made from a living organism such as bacteria and yeast or can also be ... [Published MyNewsDesk - Jul 10 2014]
First reported Jul 01 2014 - Updated Jul 01 2014 - 1 reports

BUYINS.NET: BLL, AZN Expected To Be Up Before Next Earnings Releases

BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and December earnings reports. Ball ... [Published Individual.com - Jul 01 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

AbbVie outlines rationale for Shire offer

Following Shire ’s confirmed rejection of Abbvie ’s offer on June 20, AbbVie has outlined its strategic rationale for, and background to, its proposal to the board of Shire of $34.74 in cash and 0.7988 ordinary shares of New AbbVie for each Shire share. ... [Published Center Watch - Jun 26 2014]
First reported Feb 06 2014 - Updated Feb 06 2014 - 1 reports

Human medicines European public assessment report (EPAR): Synagis, palivizumab, Revision: 26, Authorised

Entities: Palivizumab

Quotes

"She asked us what we did and thanked us," Smith said. "I have seen her before, but it was the first time I met her."
...By tracking the size and price of each montha'a "s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin."

More Content

All (18) | News (16) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
AAP updates guidance on palivizumab prophylaxis... [Published Orthopedics Today - 14 hours ago]
Premature Babies Drug in Middle of Clash Betwee... [Published The Guardian Express - 18 hours ago]
Pediatricians clash with maker of drug for babies [Published Latest Econwatch Headlines - CBS News - 19 hours ago]
Virus drugmaker fights pediatricians' new advice [Published Central Utah Daily Herald - 20 hours ago]
RSV Recommendations [Published American Academy of Pediatrics - Jul 28 2014]
Virus drugmaker fights pediatricians [Published News-Journal - Jul 28 2014]
In Brief: Virus drugmaker fights pediatricians'... [Published Erie Times-News - Jul 28 2014]
AbbVie's (ABBV) CEO Richard Gonzalez on Q2 2014... [Published Seeking Alpha - Jul 25 2014]
AbbVie Q2 Profit Rises, Results Beat View; Affi... [Published RTTNews.com - Jul 25 2014]
Market Update (NYSE:ABBV): AbbVie to Host Secon... [Published Jutia Group - Jul 23 2014]
Prevention and Management of Respiratory Viruses [Published U.S.Pharmacist - Jul 17 2014]
Mikulski tours MedImmune labs, meets with emplo... [Published Frederick News-Post - Jul 15 2014]
Mikulski Mikulski tours MedImmune labs, meets w... [Published BusinessWeek - Jul 15 2014]
Biosimilars and Biosuperiors Therapeutics Antib... [Published MyNewsDesk - Jul 10 2014]
BUYINS.NET: BLL, AZN Expected To Be Up Before N... [Published Individual.com - Jul 01 2014]
AbbVie outlines rationale for Shire offer [Published Center Watch - Jun 26 2014]
Annual Financial Report [Published TrustNet - Mar 20 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Feb 06 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Pediatricians clash with maker of drug for babies [Published Latest Econwatch Headlines - CBS News - 19 hours ago]
Leading pediatrician's group says prescription Synagis should not be given to so many kids; drugmaker fires back ...
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Feb 06 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.